Merck to use StabyExpress technology
As part of the agreement, Merck will receive a non-exclusive license to use the StabyExpress in research and product development while Delphi will receive milestone payments and royalties
The US Food and Drug Administration (FDA) has approved AstraZeneca’s Imfinzi (durvalumab) in combination with Padcev (enfortumab vedotin) for adult patients with muscle-invasive bladder cancer (MIBC) who cannot receive or have refused cisplatin-based chemotherapy.
Magnesium-enriched SoyLife product, which is produced by Israel-based Frutarom company, is a proprietary soy germ extract designed to support well-being of women experiencing menopausal symptoms. Multiple scientific studies